Scarica l'app Stockscreener
129.00
1.03%
1.31
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMDX Giù?
Forum
Previsione
Precedente Chiudi:
$127.69
Aprire:
$127.37
Volume 24 ore:
368.69K
Relative Volume:
0.36
Capitalizzazione di mercato:
$4.77B
Reddito:
$401.09M
Utile/perdita netta:
$32.64M
Rapporto P/E:
137.23
EPS:
0.94
Flusso di cassa netto:
$-120.51M
1 W Prestazione:
-0.82%
1M Prestazione:
+0.20%
6M Prestazione:
+86.71%
1 anno Prestazione:
-13.73%
Intervallo 1D:
$124.50
$129.19
Intervallo di 1 settimana:
$124.50
$136.63
Portata 52W:
$55.00
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
Nome
Transmedics Group Inc
Settore
Industria
Telefono
(978) 552-0900
Indirizzo
200 MINUTEMAN ROAD, ANDOVER, MA
Confronta TMDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
129.18 | 4.77B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
134.26 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.47 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.28 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.66 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.79 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Downgrade | Needham | Buy → Hold |
| 2024-10-29 | Reiterato | Needham | Buy |
| 2024-10-29 | Reiterato | Oppenheimer | Outperform |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-21 | Iniziato | Needham | Buy |
| 2024-06-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Iniziato | Stephens | Overweight |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2019-05-28 | Iniziato | Canaccord Genuity | Buy |
| 2019-05-28 | Iniziato | Cowen | Outperform |
| 2019-05-28 | Iniziato | JP Morgan | Overweight |
| 2019-05-28 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Transmedics Group Inc Borsa (TMDX) Ultime notizie
TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.9%Should You Sell? - MarketBeat
TransMedics Group Inc (TMDX) Trading Down 8.65% on Jun 18 - GuruFocus
TransMedics (TMDX) Continues to Scale Innovation in Organ Transplant Care - Yahoo Finance
Investors in shares of TransMedics Group, Inc. (NASDAQ:TMDX) Announced by the Shareholders Foundation in Connection with Lawsuit - Newswire :) Press Release Distribution
Boasting A 18% Return On Equity, Is TransMedics Group, Inc. (NASDAQ:TMDX) A Top Quality Stock? - Yahoo Finance
Handelsbanken Fonder AB Decreases Holdings in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group (NASDAQ:TMDX) Price Target Raised to $150.00 at Oppenheimer - Defense World
TransMedics price target raised to $150 from $130 at Oppenheimer By Investing.com - Investing.com Canada
10 Best Growth Stocks to Buy According to Billionaires - Insider Monkey
TransMedics Group (TMDX) Sees Price Target Boost by Oppenheimer - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
(TMDX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Oppenheimer Adjusts Price Target for TransMedics (TMDX) to $150 - GuruFocus
Oppenheimer Adjusts Price Target for TransMedics (TMDX) to $150 | TMDX Stock News - GuruFocus
Oppenheimer Hikes TransMedics Group Price Target to $150 From $130, Maintains Outperform Rating - MarketScreener
TransMedics Group, Inc. (NASDAQ:TMDX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Handelsbanken Fonder AB Sells 72,000 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out - ACCESS Newswire
Rhumbline Advisers Sells 537 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Bought by GAMMA Investing LLC - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Insider Anil P. Ranganath Sells 686 Shares - MarketBeat
Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May - MarketBeat
Two Sigma Investments LP Purchases Shares of 12,523 TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
TransMedics at Goldman Sachs Conference: Strategic Growth and Challenges By Investing.com - Investing.com Nigeria
TransMedics at Goldman Sachs Conference: Strategic Growth and Challenges - Investing.com
TransMedics Group, Inc. (TMDX): A Bull Case Theory - Insider Monkey
Transcript : TransMedics Group, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - marketscreener.com
3 Medical Technology Stocks Outperforming in 2025 - MarketBeat
TransMedics: Data Points To Strong Second Quarter, But Beware Of The Second Half - Seeking Alpha
GAMMA Investing LLC Boosts Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
12,523 Shares in TransMedics Group, Inc. (NASDAQ:TMDX) Acquired by Two Sigma Investments LP - Defense World
Sugar Maple Asset Management LLC Invests $740,000 in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group (NASDAQ:TMDX) Given "Hold" Rating at Needham & Company LLC - MarketBeat
Wellington Management Group LLP Sells 139,337 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Invests $4.13 Million in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group (NASDAQ:TMDX) Given “Overweight” Rating at Piper Sandler - Defense World
3 High-Growth Stocks Traders Love and Investors Should Watch - The Globe and Mail
Piper Sandler Boosts TransMedics (TMDX) PT to $145, Keeps Overweight Rating - MSN
Nuveen Asset Management LLC Sells 98,195 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group's (TMDX) "Overweight" Rating Reiterated at Piper Sandler - MarketBeat
TransMedics Group (TMDX) Price Target Raised by Piper Sandler | - GuruFocus
Piper Sandler raises TransMedics stock price target to $145 By Investing.com - Investing.com Canada
TransMedics (TMDX) Price Target Increased by Piper Sandler | TMD - GuruFocus
TransMedics (TMDX) Price Target Increased by Piper Sandler | TMDX Stock News - GuruFocus
TransMedics Group, Inc. (NASDAQ:TMDX) Director Edward M. Basile Sells 5,000 Shares - MarketBeat
TransMedics Group Inc (TMDX) Shares Up 4.58% on Jun 3 - GuruFocus
TransMedics at 45th Annual William Blair: Transforming Organ Transplants - Investing.com
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
4 Analysts Have This To Say About TransMedics Group - Nasdaq
Transmedics Group Inc Azioni (TMDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Transmedics Group Inc Azioni (TMDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Basile Edward M | Director |
May 27 '25 |
Option Exercise |
0.70 |
5,000 |
3,500 |
7,866 |
| Basile Edward M | Director |
May 27 '25 |
Sale |
126.45 |
5,000 |
632,250 |
2,866 |
0.32%
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):